Back
G1 Therapeutics Stock Price Chart
Sponsored
GTHX
Sponsored
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
32
GTHX
G1 Therapeutics
Last Price:
3.99
Seasonality Move:
17.14%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.- The current trend is moderately bearish and GTHX is experiencing slight buying pressure.
G1 Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.1 | Sell |
20-day SMA: | 4.4 | Sell |
50-day SMA: | 3.68 | Buy |
200-day SMA: | 2.61 | Buy |
8-day EMA: | 4.11 | Sell |
20-day EMA: | 4.18 | Sell |
50-day EMA: | 3.92 | Sell |
200-day EMA: | 3.35 | Buy |
G1 Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 42.62 | Sell |
Chaikin Money Flow: | 67270 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.04 - 4.66) | Sell |
Bollinger Bands (100): | (2.73 - 4.31) | Buy |
G1 Therapeutics Technical Analysis
Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for G1 Therapeutics Stock
Is G1 Therapeutics Stock a Buy?
- G1 Therapeutics share price is 3.86 while GTHX 8-day simple moving average is 4.10, which is a Sell signal.
- The stock price of GTHX is 3.86 while G1 Therapeutics 20-day SMA is 4.40, which makes it a Sell.
- G1 Therapeutics 50-day simple moving average is 3.68 while GTHX share price is 3.86, making it a Buy technically.
- GTHX stock price is 3.86 and G1 Therapeutics 200-day simple moving average is 2.61, creating a Buy signal.
GTHX Technical Analysis vs Fundamental Analysis
Sell
32
G1 Therapeutics (GTHX)
is a Sell
Is G1 Therapeutics a Buy or a Sell?
-
G1 Therapeutics stock is rated a Sell
The current G1 Therapeutics [GTHX] share price is $3.86. The Score for GTHX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
G1 Therapeutics Stock Info
Market Cap:
201.49M
Price in USD:
3.86
Share Volume:
538.16K
G1 Therapeutics 52-Week Range
52-Week High:
5.00
52-Week Low:
1.08
Sell
32
G1 Therapeutics (GTHX)
is a Sell
G1 Therapeutics Share Price Forecast
-
What is the G1 Therapeutics stock price today?
The G1 Therapeutics stock price is 3.86 USD today. -
Will GTHX stock go up or go down?
G1 Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is G1 Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, G1 Therapeutics is overvalued.
Is G1 Therapeutics Stock a Buy?
- G1 Therapeutics share price is 3.86 while GTHX 8-day exponential moving average is 4.11, which is a Sell signal.
- The stock price of GTHX is 3.86 while G1 Therapeutics 20-day EMA is 4.18, which makes it a Sell.
- G1 Therapeutics 50-day exponential moving average is 3.92 while GTHX share price is 3.86, making it a Sell technically.
- GTHX stock price is 3.86 and G1 Therapeutics 200-day simple moving average is 3.35, creating a Buy signal.
Fundamental Analysis of G1 Therapeutics
Is G1 Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $0.45 per share.
Technical Analysis of G1 Therapeutics
Should I short G1 Therapeutics stock?
- GTHX Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting G1 Therapeutics is a Buy
- G1 Therapeutics Relative Strength Index (RSI) is 42.62, which suggest G1 Therapeutics is oversold
- The Bollinger Bands (25) for G1 Therapeutics is (4.04 - 4.66), which suggest G1 Therapeutics is a Buy
- The Bollinger Bands (100) for G1 Therapeutics is (2.73 - 4.31), which suggest G1 Therapeutics is a Buy
* G1 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.